Dew assumes a fairly high degree of probability that IFN-L will be obsoleted by the first ever cure of a chronic viral disease using a course of Direct Acting Anti-virals. Therefore those later milestones for sales are not collectible by Zymo.
Obviously I substantially disagree - but it isn't worth rehashing for the 10th time.
Altogether very annoying that Zymo board was 'captured'.
News 
Market Data 
Discover 
